Filing Details

Accession Number:
0001078782-16-003581
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-10-06 12:31:45
Reporting Period:
2016-10-05
Filing Date:
2016-10-06
Accepted Time:
2016-10-06 12:31:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
93314 Volitionrx Ltd VNRX In Vitro & In Vivo Diagnostic Substances (2835) 911949078
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1650670 Matthew David Kratochvil 1 Scotts Road
#24-05 Shaw Centre
Singapore U0 228208
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-10-05 10,000 $5.00 10,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. These shares were purchased by the reporting person in connection with an underwritten public offering by the Issuer. The offering closed on October 5, 2016. The reported sale price reflects the price at which the reporting person purchased the shares from the underwriters.